Trial Profile
WEUSKOP6166: Prevalence of Aseptic Meningitis Among Lamotrigine Users
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Lamotrigine (Primary)
- Indications Bipolar disorders; Epilepsy
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK
- 14 Aug 2012 New trial record